Marijuana Cue-Reactivity and Seeking Behavior in Regular Cannabis Users: Pilot Test of Glutamatergic Modulation
Marijuana Cue-Reactivity and Seeking Behavior in Regular Cannabis Users: Pilot Test of Glutamatergic Modulation
批准号:
9325486
负责人:
LESLIE H Lundahl
金额:
$17.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-15 至 2019-07-31
关键词:
AbstinenceAcetylcysteineAcuteAddressAdolescentAnteriorAttenuatedBehaviorBehavior TherapyBehavioralBrainCannabisChronicCigaretteClinicalClinical ResearchClinical TrialsCocaineCross-Over StudiesCuesCysteineDataDoseDrug ExposureDrug usageEconomic FactorsEnvironmental Risk FactorExposure toFoundationsGlutamatesGray unit of radiation doseHealthHeroinHumanHybridsIndividualInpatientsInterventionLaboratoriesLaboratory StudyLegalLinkMaintenanceMarijuanaMediatingMissionModelingMotivationMulti-Institutional Clinical TrialNational Institute of Drug AbuseNicotineOlives - dietaryOpioidOralOutcome MeasureParticipantPathway interactionsPatient Self-ReportPatientsPharmaceutical PreparationsPharmacologyPlacebo ControlPlacebosPriceProceduresProcessProdrugsPublic HealthPublishingRandomizedRattusRelapseRiskScheduleSelf AdministrationSubstance Use DisorderSubstance abuse problemTest ResultTestingTherapeuticUrineWithdrawalWorkbehavioral economicscravingcue reactivitydisorder later incidence preventiondrug cravingdrug of abuseglutamatergic signalinggraspimprovedinnovationmarijuana usemarijuana use disordermarijuana userpre-clinicalprimary outcomepsychosocialscreeningvolunteer
中文摘要
越来越多的医学法律和社会文化对大麻使用的宽容助长了大麻的增长
英文摘要
Growing medico-legal and socio-cultural tolerance of marijuana use is fueling a rise in marijuana
availability/use despite scientific evidence that regular marijuana use carries health risks. Cannabis use
disorder (CUD) is the most commonly treated substance abuse problem, and escalating marijuana
availability/use is likely to increase demand for treatment. There is no approved medication to treat CUD,
and relapse rates after behavioral treatment are high. Despite an urgent need for pharmacological and
psychosocial interventions, optimal treatments should be predicated on clear understanding of mechanisms
that underlie marijuana use. Although it is clinically accepted that exposure to drug-related cues
foreshadows drug taking, a causal link between cue-exposure and drug use has yet to be demonstrated
under experimentally controlled conditions. Similarly, the extent to which craving mediates this link has not
been examined. The proposed study aims to establish a human laboratory model to examine the effect of
cue exposure on drug seeking (using marijuana as an exemplar) and the contribution of craving in the
cue/seeking connection. Cue-induced seeking will be examined in the context of varying unit price (using a
progressive ratio schedule) to obtain marijuana, to introduce variability in drug motivation and different
environmental conditions. This hybrid cue-exposure + choice procedure model will be used to test whether
N-acetylcysteine (NAC), a cysteine pro-drug, attenuates marijuana cue-related craving and seeking. In this
placebo-controlled, within subject, randomized crossover, inpatient study, a total of 32 individuals with CUD
will be administered NAC (0 vs 2400 mg) prior to marijuana and neutral cue exposure. Our primary outcome
measure is marijuana-seeking behavior assessed using a marijuana (vs. money) choice, PR task. In each
session, participants will be given 11 choice opportunities to work for puffs from a marijuana cigarette (7.0%
THC; max of 11 puffs) or money alternative (max of $22). Aims are to determine whether: (1) presentation
of polysensory marijuana-related vs. neutral cues increases marijuana seeking; (2) the Glu probe NAC
attenuates the effects of marijuana-related cues on craving and seeking; and, (3) marijuana cue-induced
craving mediates effects of cue exposure on drug seeking. Overall, this project will increase mechanistic
understanding of cue-induced cannabis use and provide a model for screening therapeutic approaches to
reduce health burdens of CUD. This project addresses a significant public health problem with an innovative
and strong approach, and will have a substantial and sustained impact on the field.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Smoked Marijuana Discrimination and Marijuana Choice in Humans: A Laboratory Mode
-
批准号:7864258
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2009
-
负责人:LESLIE H Lundahl
-
依托单位:
Smoked Marijuana Discrimination and Marijuana Choice in Humans: A Laboratory Mode
-
批准号:7686631
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2009
-
负责人:LESLIE H Lundahl
-
依托单位:
Cue Reactivity Model/Pharm. Intervention in Cannabis Use
-
批准号:6952437
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2004
-
负责人:LESLIE H Lundahl
-
依托单位:
Cue Reactivity Model/Pharm. Intervention in Cannabis Use
-
批准号:6878831
-
项目类别:
-
资助金额:$21.87万
-
财政年份:2004
-
负责人:LESLIE H Lundahl
-
依托单位:
MARIHUANA CUE INDUCED CRAVING AND RELAPSE IN ADOLESCENTS
-
批准号:2879357
-
项目类别:
-
资助金额:$7.37万
-
财政年份:1999
-
负责人:LESLIE H Lundahl
-
依托单位:
海外基金